Markers of Systemic Inflammatory Response Are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis

被引:0
|
作者
Gaitanidis, Apostolos [1 ]
Patel, Dhaval [1 ]
Nilubol, Naris [1 ]
Tirosh, Amit [1 ]
Sadowski, Samira [1 ]
Kebebew, Electron [1 ]
机构
[1] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S70 / S71
页数:2
相关论文
共 50 条
  • [1] Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis
    Apostolos Gaitanidis
    Dhaval Patel
    Naris Nilubol
    Amit Tirosh
    Samira Sadowski
    Electron Kebebew
    Annals of Surgical Oncology, 2018, 25 : 122 - 130
  • [2] Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis
    Gaitanidis, Apostolos
    Patel, Dhaval
    Nilubol, Naris
    Tirosh, Amit
    Sadowski, Samira
    Kebebew, Electron
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (01) : 122 - 130
  • [3] Meta-Analysis of Prognostic Biomarkers for Pancreatic Neuroendocrine Tumors (PNETS)
    Zhu, Mojun
    Halfdanarson, Thorvardur
    Rothberg, Bonnie
    PANCREAS, 2020, 49 (03) : 491 - 491
  • [4] Meta-analysis of prognostic biomarkers for pancreatic neuroendocrine tumors (PNETs).
    Zhu, Mojun
    Halfdanarson, Thorvardur Ragnar
    Rothberg, Bonnie Elyssa Gould
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)
    Wang, Zhe
    Cao, Feng
    Zhang, Yupeng
    Fang, Yu
    Li, Fei
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [6] ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors
    Gaitanidis, Apostolos
    Patel, Dhaval
    Kebebew, Electron
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 874 - 875
  • [7] ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors
    Apostolos Gaitanidis
    Dhaval Patel
    Electron Kebebew
    Annals of Surgical Oncology, 2018, 25 : 874 - 875
  • [8] Prognostic Factors of Survival in Patients with Pancreatic Neuroendocrine Tumors
    Popovic, B.
    Bozic, I
    Macut, D.
    Isailovic, T.
    Ognjanovic, S.
    Elezovic, V
    Petakov, M.
    Micev, M.
    Damjanovic, S.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 131 - 131
  • [9] Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors (PNETs)
    Berardi, R.
    Torniai, M.
    Pusceddu, S.
    Spada, F.
    Ibrahim, T.
    Zichi, C.
    Antonuzzo, L.
    Ferolla, P.
    Rinzivillo, M.
    Silvestris, N.
    Partelli, S.
    Ferretti, B.
    Bongiovanni, A.
    Giustini, L.
    Di Costanzo, F.
    Delle Fave, G.
    Fazio, N.
    De Braud, F. G. M.
    Falconi, M.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors (PNETs)
    Berardi, R.
    Pusceddu, S.
    Spada, F.
    Ibrahim, T.
    Brizzi, M. P.
    Antonuzzo, L.
    Ferolla, P.
    Rinzivillo, M.
    Silvestris, N.
    Freddari, F.
    Testa, E.
    Bongiovanni, A.
    Zichi, C.
    Di Costanzo, F.
    Delle Fave, G.
    Fazio, N.
    de Braud, F.
    Falconi, M.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2016, 27